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Background
Plasmacytoid dendritic cells (pDCs) play a central role in
innate and adaptive immunity to viral infections, including
HIV-1. pDCs produce substantial quantities of type I IFN
and proinflammatory cytokines upon stimulation by Toll-
like receptors (TLR), specifically TLR7 or TLR9. We have
studied how gp120 affects human pDC responses to TLR9
agonists, and the subsequent ability of the pDCs to stimu-
late B cells, with the goal of learning how better to induce
B cell responses to Env protein vaccines.
Methods
pDCs were isolated from human peripheral blood using
CD304 magnetic beads, and then treated with endotoxin-
free recombinant gp120 during stimulation with TLR9
agonists. IFN-a, IL-6, TNF-a, IRF-7 and BAFF were quan-
tified at the protein or mRNA level. Co-cultures were per-
formed to study how gp120-treatment of the pDCs
affected their abilities to stimulate B cell responses, specifi-
cally proliferation, differentiation to plasma cells and IgG/
IgM production.
Results
We found that gp120 impaired IFN-a production by pDCs
in response to TLR9 (CpG-ODN), but not TLR7, stimula-
tion. Receptor-blocking studies showed the inhibitory
effects were mediated via CD4 and the C-type lectin
receptor BDCA-2, but not via CCR5 or CXCR4. Treat-
ment with gp120 inhibited CpG-induced pDC maturation,
TNF-a and IL-6 production and IRF-7 and BAFF mRNA
expression. The gp120-treated, CpG-activated pDCs also
had impaired abilities to induce B cell proliferation, plasma
cell differentiation and Ig production, due at least in part
to decreased expression of BAFF and other cytokines.
Conclusion
Taken together, our data show that HIV-1 gp120
impairs pDC functions and B cell activation, and imply
that TLR9 ligands may not be good adjuvants to use in
combination with Env-based vaccines.
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